LifeCell Corporation - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for LifeCell Corporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

LifeCell Corporation. The Company's principal activity is to develop and market biologically based solutions for the repair and replacement of damaged or inadequate human tissues in different clinical applications. The Company's patented tissue-processing technology produces a regenerative tissue matrix, which is a complex three-dimensional structure that contains vascular channels, proteins and growth factor-binding sites that provides a complete template for the regeneration of normal human tissue. The products of the Company include: AlloDerm for plastic reconstructive, burn and periodontal procedures; Cymetra for non-surgical correction of soft tissue defects; Repliform for urology and gynecology procedures; cryopreserved allograft skin for use as a temporary wound dressing in the treatment of burns; Cymetra, a version of AlloDerm in particulate form; Repliform for urogynecologic procedures; Graft Jacket for orthopedic applications and Allocratf DBM for bone grafting.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report